MedTrace Logo

A Prospective Registry of Vaginal Photobiomodulation for Chronic Pelvic Pain.

NCT07799857 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-09-02

No results posted yet for this study

Summary

The VOICE Registry is a multicenter, prospective, observational registry designed to collect real-world data on the clinical use of SoLá Pelvic Therapy® (SPT) in patients with chronic pelvic pain (CPP). The registry will follow patients receiving transvaginal photobiomodulation (PBM) therapy with SPT as part of their standard clinical care. The primary purpose of the registry is to collect real-world evidence on the use and safety of SPT.

Conditions

  • Chronic Pelvic Pain

Interventions

DEVICE

SoLá Pelvic Therapy (SPT)

SoLá Pelvic Therapy (SPT) is administered as part of routine clinical care to patients with chronic pelvic pain. Treatment is not assigned by the registry. The registry prospectively collects treatment, and safety information from patients receiving SPT at participating sites.

Sponsors & Collaborators

  • Uroshape LLC

    collaborator UNKNOWN

  • SoLa Pelvic Therapy

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-06
Primary Completion
2029-04-30
Completion
2030-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07799857 on ClinicalTrials.gov